Swiss Doctors Study LSD for End-of-Life Anxiety

Why this is here: Cancer patients in the study actively pursued new life experiences—like travel or further education—after receiving LSD, rather than passively awaiting the end of life.

A group of Swiss doctors are scientifically investigating whether LSD can alleviate anxiety in patients receiving palliative care. The doctors hope to prove LSD’s therapeutic potential, building on past research into its use for depression. Bill Richards, a pioneer in LSD research, explains that a carefully administered dose in a safe environment can offer profound emotional healing.

Richards notes the substance can accelerate therapy, helping people process grief, guilt, and fear related to death. Patients report continued pain, but with lessened emotional burden and acceptance of their mortality. Many cancer patients, after experiencing this, pursue new activities—traveling, studying, creating art—and avoid self-pity.

The Swiss study seeks to remain open-minded and prioritize meaningful results. Richards believes Switzerland is leading the way in exploring LSD’s value in palliative medicine. While more research is needed, early indications suggest LSD can help people live fuller lives even as they approach death.